Can Citalopram 20 mg Be Safely Restarted After a 4-5 Day Interruption?
Yes, citalopram 20 mg can be safely restarted after a 4-5 day interruption, but you should restart at the same dose the patient was previously taking (if it was 20 mg), monitor closely for the first 24-48 hours, and be aware that some patients may experience reduced responsiveness to the medication after interruption.
Key Considerations for Restarting
Dosing Strategy
The FDA label 1 specifies that citalopram should be initiated at 20 mg once daily, which is the standard starting dose. After a 4-5 day interruption:
- If the patient was previously stable on 20 mg: Restart at 20 mg daily
- If the patient was on a higher dose (e.g., 40 mg): Consider restarting at 20 mg and titrating back up, as the drug will have been largely eliminated (citalopram half-life is approximately 42 hours for S-citalopram and 66 hours for R-citalopram) 2
- Maximum dose remains 40 mg/day due to QT prolongation risk 3, 1
Critical Monitoring Period
Monitor intensively during the first 24-48 hours after restarting 3. This is when serotonin syndrome risk is highest if the patient is on other serotonergic medications, and when withdrawal symptoms may still be present or rebound.
Watch for:
- Mental status changes (confusion, agitation, anxiety)
- Neuromuscular hyperactivity (tremors, clonus, hyperreflexia)
- Autonomic hyperactivity (hypertension, tachycardia, diaphoresis)
- Withdrawal symptoms that may persist (dizziness, fatigue, paresthesias, irritability)
Important Warnings After Interruption
Risk of Reduced Responsiveness
A critical but under-recognized issue: 4-57% of patients who stop and restart antidepressants experience loss of responsiveness to previously effective treatment 4. This means the medication may not work as well as it did before the interruption. If the patient doesn't respond within 4-8 weeks of restarting, consider this phenomenon rather than assuming treatment failure.
Withdrawal Symptoms May Still Be Present
After 4-5 days off citalopram, the patient is likely experiencing withdrawal symptoms, as citalopram has a relatively short half-life 3. Common withdrawal symptoms include:
- Dizziness, vertigo, imbalance
- Fatigue, lethargy
- Paresthesias, sensory disturbances
- Anxiety, irritability, agitation
- Nausea, vomiting
- Headaches
These symptoms typically emerge within days of discontinuation and should improve within 1-2 weeks of restarting 1.
QT Prolongation Considerations
Before restarting, assess QT prolongation risk 5, 3:
Consider obtaining an ECG if the patient has:
- Age > 60 years (maximum dose should be 20 mg/day in this population) 1
- Concurrent QT-prolonging medications
- Electrolyte disturbances (hypokalemia, hypomagnesemia)
- Structural heart disease
- Female sex (higher risk)
- Baseline QTc > 450 ms
Citalopram carries the highest QT prolongation risk among SSRIs 5, 6. Daily doses exceeding 40 mg are associated with Torsades de Pointes, ventricular tachycardia, and sudden death 3.
Special Populations Requiring Dose Adjustment
Maximum 20 mg/day for 1:
- Patients > 60 years old
- Hepatic impairment
- CYP2C19 poor metabolizers
- Concurrent use of CYP2C19 inhibitors (e.g., cimetidine)
Drug Interactions to Verify
Before restarting, confirm the patient is NOT taking 1:
- MAOIs (contraindicated; requires 14-day washout period)
- Pimozide (contraindicated)
- Linezolid or IV methylene blue (contraindicated due to serotonin syndrome risk)
Exercise caution with other QT-prolonging drugs 5, 3.
Why the Interruption Occurred Matters
If the interruption was intentional (patient wanted to stop): Discuss why they want to restart and whether alternative treatments might be more appropriate, given the risk of reduced responsiveness 4.
If the interruption was unintentional (missed doses, access issues): Address barriers to adherence before restarting to prevent future interruptions.
Common Pitfall to Avoid
Do NOT use alternate-day dosing when restarting or tapering citalopram. Recent modeling shows that dosing every other day causes pronounced receptor occupancy variation and significantly increases withdrawal symptom risk, even at low doses 7, 8. If dose reduction is needed, use daily dosing with smaller increments (liquid formulations if necessary).